Table: Oncolys Biopharma - 6-MTH parent results

Oncolys Biopharma

07/08/2026 06:30

    Aug 7 (Reuters)- 
             Oncolys Biopharma Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Jun 30, 2026        Jun 30, 2025     Dec 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            503 mln             28 mln                     
                (+1662.4 pct)        (-9.0 pct)                   
  Operating     loss 767 mln          loss 1.27                   
  Recurring     loss 760 mln          loss 1.31                   
  Net           loss 762 mln          loss 1.31                   
  EPS          loss 26.03 yen      loss 52.85 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL              NIL     
  
  NOTE - Oncolys Biopharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T